MedTrace Logo

Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

NCT05292885 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-03-23

No results posted yet for this study

Summary

It is an open label observation clinical trial, all participants are liver transplant patients. The investigators deem to make a better criteria for assessing liver fibrosis after liver transplantation. The point of the clinical trial is to evaluate the efficacy of multiparameter MRI in the diagnosis of liver fibrosis after liver transplantation.

Conditions

  • Liver Fibrosis After Liver Transplantation
  • Multiparameter Magnetic Resonance Imaging

Interventions

DIAGNOSTIC_TEST

Gadopentetate Dimeglumine Injection

Patients with liver fibrosis after liver transplantation receive multi-parameter magnetic resonance scanning, percutaneous liver biopsy (or FibroScan).

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    lead OTHER

Principal Investigators

  • Guangjie Yang, PhD · The affiliated hostpital of Qingdao University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-18
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05292885 on ClinicalTrials.gov